Author

R. A. Harbison

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

U. Duvvuri· 2 shared A. VYAS· 1 shared A. Yassin-Kassab· 1 shared D. Faden· 1 shared D. Palmer· 1 shared E. Mendez· 1 shared H. Osmanbeyoglu· 1 shared J. R. Foley· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

U. Duvvuri

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJul 25, 2023

Polyamine transport inhibition and cisplatin synergistically enhance tumor control through oxidative stress in murine head and neck cancer models

A. Yassin-Kassab, N. Wang, J. R. Foley…·U. Duvvuri

This study shows that combining cisplatin with AMXT-1501 enhances tumor control in HNSCC models by increasing oxidative stress and apoptosis, independent of polyamine levels.

DOI 10.1016/j.oor.2023.100123

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivAug 21, 2020

Recurrent human papillomavirus-related head and neck cancer undergoes metabolic re-programming and is driven by oxidative phosphorylation

A. VYAS, R. A. Harbison, D. Faden…·U. Duvvuri

This study identifies oxidative phosphorylation as a driver of treatment failure in recurrent HPV-related head and neck cancer, highlighting Nrf2 as a therapeutic target.

DOI 10.1158/1078-0432.ccr-20-4789

humanbulk RNA-seq

𝕏 PostBluesky